Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroprotective Effect of High Dose Erythropoietin in Very Preterm Infants
NCT00413946Phase 2Completed
- Sponsor
- Swiss Neonatal Network
- Start
- Jan 2006
- Primary completion
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of erythropoietin in intracranial hemorrhage (ICH), periventricular leukomalacia (PVL), cerebral palsy (CP), Psychomotor impairment, sponsored by Swiss Neonatal Network. Started Jan 2006; status: completed.
02
Drugs
erythropoietin
03
Conditions
intracranial hemorrhage (ICH)periventricular leukomalacia (PVL)cerebral palsy (CP)Psychomotor impairment
Beyond the preview
Go deeper on NCT00413946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00413946.